Current Perspectives in Antiviral Research.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
26 Sep 2023
Historique:
received: 15 09 2023
accepted: 22 09 2023
medline: 2 11 2023
pubmed: 14 10 2023
entrez: 14 10 2023
Statut: epublish

Résumé

Studies on virus-host interactions are of high significance for a number of reasons [...].

Identifiants

pubmed: 37833992
pii: ijms241914555
doi: 10.3390/ijms241914555
pmc: PMC10572941
pii:
doi:

Substances chimiques

Antiviral Agents 0

Types de publication

Editorial

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministry of Science and Higher Education of the Russian Federation
ID : The creation and development of World-Class Research Centers 'Digital Biodesign and Person-alized Healthcare' (No 75-15-2022-305).

Références

Curr Opin Virol. 2021 Dec;51:56-64
pubmed: 34597873
Int J Mol Sci. 2023 Jan 11;24(2):
pubmed: 36674980
Lancet. 2018 Mar 31;391(10127):1301-1314
pubmed: 29307467
ALTEX. 2022 Jul 15;40(1):174-186
pubmed: 35867862
J Coll Physicians Surg Pak. 2017 Sep;27(9):572-573
pubmed: 29017675
Front Immunol. 2019 May 03;10:1002
pubmed: 31130969
Proc Natl Acad Sci U S A. 2022 May 10;119(19):e2201288119
pubmed: 35507870
Int J Mol Sci. 2023 Jul 30;24(15):
pubmed: 37569570
Nature. 2023 Jan;613(7944):558-564
pubmed: 36351451
Cancer Treat Rev. 2018 May;66:15-22
pubmed: 29631196
Cell Mol Life Sci. 2019 Sep;76(18):3525-3542
pubmed: 31101936
N Engl J Med. 2018 Mar 15;378(11):1029-1041
pubmed: 29539283
Int J Mol Sci. 2020 Jul 22;21(15):
pubmed: 32707869
Database (Oxford). 2019 Jan 1;2019:
pubmed: 30753475
J Chem Inf Model. 2010 Jul 26;50(7):1189-204
pubmed: 20572635
J Med Virol. 2022 May;94(5):1825-1832
pubmed: 35023191
Rev Esp Quimioter. 2022 Oct;35 Suppl 3:10-15
pubmed: 36285850
Int J Biol Macromol. 2021 Mar 1;172:524-541
pubmed: 33454328
Int J Mol Sci. 2022 Feb 24;23(5):
pubmed: 35269659
Mol Syst Biol. 2021 Nov;17(11):e10396
pubmed: 34709727
Viruses. 2021 Jul 14;13(7):
pubmed: 34372568
Int J Mol Sci. 2021 May 20;22(10):
pubmed: 34065594
Infect Genet Evol. 2016 Dec;46:292-307
pubmed: 27587334
Crit Rev Oncol Hematol. 2022 Jun;174:103675
pubmed: 35381343
PLoS One. 2016 Dec 20;11(12):e0168576
pubmed: 27997613
Int J Mol Sci. 2021 Jan 21;22(3):
pubmed: 33494284
Int J Mol Sci. 2021 Jul 09;22(14):
pubmed: 34298992
Semin Immunopathol. 2020 Feb;42(1):61-74
pubmed: 31989228
J Innate Immun. 2020;12(1):4-20
pubmed: 31610541
Curr Opin HIV AIDS. 2017 Jan;12(1):31-38
pubmed: 27607596
Viruses. 2021 Oct 17;13(10):
pubmed: 34696520
AIDS. 2020 Aug 1;34(10):1570-1572
pubmed: 32675567
Nature. 2021 Oct;598(7881):504-509
pubmed: 34616043
Dis Esophagus. 2020 Dec 7;33(12):
pubmed: 32462190
Comput Struct Biotechnol J. 2021 Apr 25;19:2447-2459
pubmed: 34025935
Crit Rev Clin Lab Sci. 2018 Mar;55(2):102-114
pubmed: 29316828
Lancet Microbe. 2022 May;3(5):e392-e398
pubmed: 35544100

Auteurs

Olga A Tarasova (OA)

Laboratory of Structure-Function Based Drug Design, Institute of Biomedical Chemistry, 10 Bldg. 8, Pogodinskaya Str., 119121 Moscow, Russia.

Articles similaires

Animals Swine Antiviral Agents Swine Diseases Coronavirus Infections
Humans Carcinoma, Hepatocellular Liver Neoplasms Aged United States
Host Specificity Bacteriophages Genomics Algorithms Escherichia coli

Glucose and glutamine drive hepatitis E virus replication.

Shaheen Khan, Suruchi Aggarwal, Pooja Bhatia et al.
1.00
Glutamine Virus Replication Hepatitis E virus Glucose Glycolysis

Classifications MeSH